LI JIANWEI (Chairman and Co-CEO) purchased 12.8% of their position (141.97K shares) of ESTRELLA IMMUNOPHARMA, INC. on the open market
Open‑market purchase worth $44.68B — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/17/2022ACC: 0001104659-22-035068
DirectorOfficer10% Owner· Chairman and Co-CEO
Since Jul 2021
+141.97K
Net shares
Net buyer
$44.68B
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
141.97K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+141.97K
Price / share
$314.70K
Trade value
$44.68B
% of position
12.8%
3/4/2022
1.11M→1.25M
Total
Net shares
+141.97K
Net value
$44.68B
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2022 | P · Purchase | +141.97K | $314.70K | $44.68B | 12.8% | 1.11M | 1.25M |
| Total | +141.97K | $44.68B | ||||||
Derivative Transactions0
No derivative transactions reported